Cargando…

Effect of clopidogrel on the hydroxylation and sulfoxidation of omeprazole: A single dose study in healthy human volunteers

Based upon the known potential interaction between omeprazole (OMP) and clopidogrel (CLOP), the current study was designed to evaluate the effect of CLOP on disposition of OMP and its two major metabolites, 5-hydroxyomeprazole (5-OH-OMP) and omeprazole sulfone (OMP-S) in healthy clinical subjects. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmad, Lateef, Iqbal, Zafar, Nazir, Shabnam, Khan, Abad, Shah, Yasar, Khan, Muhammad Imran, Khan, Ismail, Khan, Amjad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Leibniz Research Centre for Working Environment and Human Factors 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427475/ https://www.ncbi.nlm.nih.gov/pubmed/28507476 http://dx.doi.org/10.17179/excli2016-658

Ejemplares similares

Enhancement of dissolution rate of class II drugs (Hydrochlorothiazide); a comparative study of the two novel approaches; solid dispersion and liqui-solid techniques
por: Khan, Amjad, et al.
Publicado: (2015)

The Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Japanese Volunteers
por: Umemura, Kazuo, et al.
Publicado: (2016)

Pharmacokinetics and bioequivalence evaluation of omeprazole and sodium bicarbonate dry suspensions in healthy Chinese volunteers
por: Zhang, Rui, et al.
Publicado: (2023)

Hydroxylation index of omeprazole in relation to CYP2C19 polymorphism and sex in a healthy Iranian population
por: Payan, Maryam, et al.
Publicado: (2014)

Impact of Grapefruit Juice on the Antiplatelet Activity of Loading and Maintenance Doses of Clopidogrel in Healthy Volunteers
por: Campbell, Jennifer A., et al.
Publicado: (2014)

Cost-Effectiveness and Cost–Utility Analysis of the Use of Clopidogrel and Pantoprazole in Comparison with Clopidogrel and Omeprazole for the Secondary Prevention of Myocardial Infarction in Iran
por: Amirsadri, Mohammadreza, et al.
Publicado: (2021)

Celecoxib Does Not Attenuate the Antiplatelet Effects of Aspirin and Clopidogrel in Healthy Volunteers
por: Lee, Wonjae, et al.
Publicado: (2010)

Formulation Development and Characterization of pH Responsive Polymeric Nano-Pharmaceuticals for Targeted Delivery of Anti-Cancer Drug (Methotrexate)
por: Ullah, Farhad, et al.
Publicado: (2022)

Pharmacokinetic and pharmacodynamic effects of comedication of clopidogrel and dabigatran etexilate in healthy male volunteers
por: Härtter, Sebastian, et al.
Publicado: (2012)

Effects of CYP2C19 Genetic Polymorphisms on PK/PD Responses of Omeprazole in Korean Healthy Volunteers
por: Park, Sunny, et al.
Publicado: (2017)

Concomitant Intake of Coca‐Cola to Manage the Drug–Drug Interaction Between Velpatasvir and Omeprazole Studied in Healthy Volunteers
por: van Seyen, Minou, et al.
Publicado: (2019)

Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients.
por: Antonopoulou, Smaragdi, et al.
Publicado: (2003)

Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution?
por: Kenngott, S, et al.
Publicado: (2010)

Design and Characterization of Paclitaxel-Loaded Polymeric Nanoparticles Decorated With Trastuzumab for the Effective Treatment of Breast Cancer
por: Sakhi, Mirina, et al.
Publicado: (2022)

Evaluation of the relationship between polymorphisms in CYP2C19 and the single‐dose pharmacokinetics of omeprazole in healthy Chinese volunteers: A multicenter study
por: Zhou, Shuang, et al.
Publicado: (2022)

Comparative fasting bioavailability of two clopidogrel formulations in healthy Mediterranean volunteers: an in vitro–in vivo correlation
por: Zaid, Abdel Naser, et al.
Publicado: (2015)

Hydroxyl Radical Modification of Immunoglobulin G Generated Cross-Reactive Antibodies: Its Potential Role in Systemic Lupus Erythematosus
por: Al-Shobaili, Hani A., et al.
Publicado: (2011)

A randomized, crossover pharmacodynamic study of immediate‐release omeprazole/sodium bicarbonate and delayed‐release lansoprazole in healthy adult volunteers
por: Pratha, Vijayalakshmi S., et al.
Publicado: (2016)

The CYP2C19(∗)1/(∗)2 Genotype Does Not Adequately Predict Clopidogrel Response in Healthy Malaysian Volunteers
por: Nasyuhana Sani, Yanti, et al.
Publicado: (2013)

Effects of omeprazole or pantoprazole on platelet function in non-ST-segment elevation acute coronary syndrome patients receiving clopidogrel
por: Gu, Ruo-Xi, et al.
Publicado: (2016)

Effects of Omeprazole on Iron Absorption: Preliminary Study
por: Tempel, Mila, et al.
Publicado: (2013)

Effects of ilaprazole on the steady-state pharmacodynamics of clopidogrel in healthy volunteers: An open-label randomized crossover study
por: Ye, Zekang, et al.
Publicado: (2022)

Effect of Multiple Doses of Omeprazole on the Pharmacokinetics, Safety, and Tolerability of Roxadustat in Healthy Subjects
por: Groenendaal-van de Meent, Dorien, et al.
Publicado: (2018)

A Rare Case of Thrombotic Thrombocytopenic Purpura Caused by Pancreatitis and Clopidogrel
por: Rawala, Muhammad Shabbir, et al.
Publicado: (2018)

Effects of Cyclodextrins (β and γ) and l-Arginine on Stability and Functional Properties of Mucoadhesive Buccal Films Loaded with Omeprazole for Pediatric Patients
por: Khan, Sajjad, et al.
Publicado: (2018)

Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole
por: Ochoa, Dolores, et al.
Publicado: (2020)

Computational redesign of cytochrome P450 CYP102A1 for highly stereoselective omeprazole hydroxylation by UniDesign
por: Huang, Xiaoqiang, et al.
Publicado: (2023)

Editorial: The practical implication of clinical pharmacokinetics in drug development, pharmaceutical analysis, and clinical research
por: Khan, Abad, et al.
Publicado: (2023)

The Effects of Filter’s Class, Cutoff Frequencies, and Independent Component Analysis on the Amplitude of Somatosensory Evoked Potentials Recorded from Healthy Volunteers
por: Navid, Muhammad Samran, et al.
Publicado: (2019)

CYP2C19 loss‐of‐function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel
por: Ramste, Markus, et al.
Publicado: (2023)

Pharmacogenetic Selection of Volunteers Increases Stringency of Bioequivalence Studies; The Case of Clopidogrel
por: Garcés-Eisele, J., et al.
Publicado: (2014)

Surgery for Tetralogy of Fallot in Adults: Early Outcomes
por: Khan, Imran, et al.
Publicado: (2016)

Structural confirmation of sulconazole sulfoxide as the primary degradation product of sulconazole nitrate
por: Xu, Qun, et al.
Publicado: (2018)

Impact of Albumin and Omeprazole on Steady-State Population Pharmacokinetics of Voriconazole and Development of a Voriconazole Dosing Optimization Model in Thai Patients with Hematologic Diseases
por: Khan-asa, Buddharat, et al.
Publicado: (2020)

Omeprazole-associated rhabdomyolysis
por: Tanaka, Kumiko, et al.
Publicado: (2014)

¿Omeprazol para todos?
por: Sánchez, Diego P., et al.
Publicado: (2014)

Effects of elagolix on the pharmacokinetics of omeprazole and its metabolites in healthy premenopausal women
por: Nader, Ahmed, et al.
Publicado: (2022)

Evaluation of a long‐acting injectable formulation of omeprazole in healthy dogs
por: Odunayo, Adesola, et al.
Publicado: (2022)

A Rare Case of Clopidogrel-Induced Migratory Polyarthritis in a Patient With Recent Myocardial Infarction
por: Khan, Zahid, et al.
Publicado: (2022)

P450-BM3-Catalyzed Sulfoxidation versus Hydroxylation: A Common or Two Different Catalytically Active Species?
por: Wang, Jian-bo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rqb745tlr1nhsn98ts5i9bgiih